The immunophenotypic characterization of carcinomas in situ using E-cadherin and β-catenin, combined with the analysis of cytological and architectural patterns, is a useful tool for the morphological and immunophenotypical classification of CISM. The gene discussed is CDH1; the disease is cancer.